86 related articles for article (PubMed ID: 14755887)
1. Expert consensus on the clinical application of recombinant adenovirus human p53 for head and neck cancers.
Li Y; Guo W; Li X; Zhang J; Sun M; Tang Z; Ran W; Yang K; Huang G; Li L
Int J Oral Sci; 2021 Nov; 13(1):38. PubMed ID: 34785635
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma.
Clayman GL; el-Naggar AK; Lippman SM; Henderson YC; Frederick M; Merritt JA; Zumstein LA; Timmons TM; Liu TJ; Ginsberg L; Roth JA; Hong WK; Bruso P; Goepfert H
J Clin Oncol; 1998 Jun; 16(6):2221-32. PubMed ID: 9626224
[TBL] [Abstract][Full Text] [Related]
3. Selective intra-arterial infusion of rAd-p53 with chemotherapy for advanced oral cancer: a randomized clinical trial.
Li Y; Li LJ; Wang LJ; Zhang Z; Gao N; Liang CY; Huang YD; Han B
BMC Med; 2014 Jan; 12():16. PubMed ID: 24479409
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus Ad-p53AIP1-mediated gene therapy and its regulation of p53-MDM2 interactions.
Jiang Y; Chen H; Jia H; Xu Y; Liu G; Wang Y; Yang X; Lu Y
Exp Ther Med; 2010 Mar; 1(2):363-368. PubMed ID: 22993550
[TBL] [Abstract][Full Text] [Related]
5. DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancer.
Gjerset RA
J Mol Histol; 2006 Sep; 37(5-7):239-51. PubMed ID: 16855788
[TBL] [Abstract][Full Text] [Related]
6. Diffuse EGFR staining is associated with reduced overall survival in locally advanced oesophageal squamous cell cancer.
Gibault L; Metges JP; Conan-Charlet V; Lozac'h P; Robaszkiewicz M; Bessaguet C; Lagarde N; Volant A
Br J Cancer; 2005 Jul; 93(1):107-15. PubMed ID: 15986037
[TBL] [Abstract][Full Text] [Related]
7. Conference report--gene therapy--quality matters.
Mariani SM
MedGenMed; 2004 Jul; 6(3):20. PubMed ID: 15520643
[No Abstract] [Full Text] [Related]
8. Adenoviral p53 gene therapy in squamous cell cancer of the head and neck region.
Edelman J; Edelman J; Nemunaitis J
Curr Opin Mol Ther; 2003 Dec; 5(6):611-7. PubMed ID: 14755887
[TBL] [Abstract][Full Text] [Related]
9. Head and neck cancer: response to p53-based therapeutics.
Nemunaitis J; Nemunaitis J
Head Neck; 2011 Jan; 33(1):131-4. PubMed ID: 20222046
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck.
Liu TJ; el-Naggar AK; McDonnell TJ; Steck KD; Wang M; Taylor DL; Clayman GL
Cancer Res; 1995 Jul; 55(14):3117-22. PubMed ID: 7606733
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
Horowitz J
Curr Opin Mol Ther; 1999 Aug; 1(4):500-9. PubMed ID: 11713766
[TBL] [Abstract][Full Text] [Related]
12. The current status of gene therapy.
Clayman GL
Semin Oncol; 2000 Aug; 27(4 Suppl 8):39-43. PubMed ID: 10952437
[TBL] [Abstract][Full Text] [Related]
13. Restoration of tumour suppressor gene expression for cancer.
Roth JA
Forum (Genova); 1998; 8(4):368-76. PubMed ID: 9863031
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
